Stocks
Allogene Therapeutics (ALLO) Number of ordinary shares US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Number of ordinary shares, mln | 101.1 | 120.4 | 135.8 | 143.1 | 156.9 | 209.2 | |||
| Changes by years, y/y, % | +249% | +19% | +13% | +5% | +10% | +40.2% | |||
Allogene Therapeutics. Number of ordinary shares, mln
Allogene Therapeutics. Number of ordinary shares, changes, %
Allogene Therapeutics (ALLO) Number of ordinary shares US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Number of ordinary shares, mln | 167.6 | 168.3 | 169.1 | 190.0 | 209.2 | 209.2 | ||
| Changes by years, y/y, % | +17% | +17% | +17% | +29% | +25% | |||
| Changes by quarters, q/q, % | +14% | +0% | +0% | +12% | +10% | |||
